Early diagnosis of pulmonary arterial hypertension improves five-year survival by 42%, compared with delayed diagnosis, a ...

The first COPD patient has been dosed in a Phase 1b COPD trial testing Bambusa Therapeutics’ dual-target therapy BBT002.

What Happened? Shares of biotech company Regeneron (NASDAQ:REGN) jumped 2.9% in the morning session after Bank of America ...

Patients who have comorbid COPD with heart failure and ischemic heart disease have increased health care resource use and higher mortality.

Spiro Medical announced today that it closed a $67 million Series A equity financing to support its neuromodulation system.

About Recludix Recludix is a clinical-stage company with leading, innovative platform approaches to discover and develop potent and selective inhibitors of challenging protein targets. The company’s ...

Mount Sinai analysis looks at the effectiveness of electrocardiograms analyzed via deep learning as a tool for early COPD detection ...

As of Wednesday, January 07, Mereo BioPharma Group plc’s MREO share price has surged by 9.18%, which has investors questioning if this is right time to sell.

People in Worcester's Grafton Hills neighborhood have been bracing for sudden outages since the day after Thanksgiving.

Authorities say Hocking called 911 at 12:20 a.m. to admit he shot his 86-year-old wife and told a dispatcher that officers would find them in the parking lot of a strip mall on Mowry Avenue, about an ...

A new development in wireless sensing technology that can reliably screen for five common pulmonary diseases could lead to ...

Columnist Caroline Gainer remembers a horseback ride that taught her a lesson about how to respond when you find yourself ...